Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study Looking at Women's Experiences After a Miscarriage

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by California State University, Stanislaus.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Stanford University
Information provided by:
California State University, Stanislaus
ClinicalTrials.gov Identifier:
NCT01223482
First received: October 18, 2010
Last updated: December 16, 2010
Last verified: September 2010

October 18, 2010
December 16, 2010
October 2010
February 2011   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01223482 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Study Looking at Women's Experiences After a Miscarriage
An Investigation of Women's Experiences Following Karyotyping Products of Conception After a Miscarriage

Studies have shown that a majority of pregnancies that end in miscarriage are due to a chromosome abnormality usually involving a duplicated or missing chromosome. Often this happens by chance and is not likely to occur in future pregnancies. For many women, a miscarriage can be a traumatic experience and can cause feelings of loss and grief. The option of genetic testing, such as karyotyping, may offer an explanation for the miscarriage and may help some women find closure in their loss. However, no literature exists on a women's experience with genetic testing following a miscarriage. This assumption that the knowledge that can be gained from karyotyping may be a positive experience for a woman following a miscarriage should be studied and the results published. This study will address whether routine karyotyping should be offered following a miscarriage for the purpose of benefiting the patient's experience.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample

The investigators are targeting woman based on the inclusion and exclusion criteria provided below.

Miscarriage
Not Provided
  • Miscarriage with genetic testing
    This is a study population of women that have had a miscarriage and had genetic testing performed. The investigators would like to know what their experiences were following their miscarriage and testing.
  • Miscarriage without genetic testing
    This cohort is considered the control group. These women have not had genetic testing done, but are asked questions regarding their miscarriage experience.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
400
June 2011
February 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • The inclusion criteria for this project will be females, 18 years or older, of any ethnicity that have had a 1st trimester miscarriage within the last one year, who currently reside in the US and have done so for the past one year.

Exclusion Criteria:

  • Exclusion criteria will be males, females younger than 18 years of age, females with a miscarriage over one year, non-US residents and US residents where the miscarriage occurred outside of the US.
Female
18 Years and older
Yes
Contact: Diem T Huynh, B.S. 650-483-5827 diem218@gmail.com
United States
 
NCT01223482
1011-017
Yes
Janey Youngblom, CSU Stanislaus
California State University, Stanislaus
Stanford University
Not Provided
California State University, Stanislaus
September 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP